NanoVibronix, Inc. (NAOV) |
|
3.3171 -0.213 (-6.03%)
|
06-06 15:44 |
|
Open: |
3.32 |
Pre. Close: |
3.53 |
|
High:
|
3.49 |
Low:
|
3.31 |
|
Volume:
|
4,610 |
Market Cap:
|
6(M) |
|
|
|
Technical analysis |
as of: 2023-06-06 3:50:52 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
  |
| Target: |
Six months: 4.6 One year: 5.06 |
| Support: |
Support1: 3.3 Support2: 2.75 |
| Resistance: |
Resistance1: 3.94 Resistance2: 4.34 |
| Pivot: |
3.76 |
| Moving Average: |
MA(5): 3.64 MA(20): 3.76
MA(100): 4.23 MA(250): 7.58 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 18.8  %D(3): 21.3 |
| RSI: |
RSI(14): 44.6 |
| 52-week: |
High: 15.39 Low: 2.94 |
| Average Vol(K): |
3-Month: 13 (K) 10-Days: 9 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NAOV ] has closed above bottom band by 12.2%. Bollinger Bands are 47.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 64 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.61 - 3.63 |
3.63 - 3.64 |
|
Low:
|
3.36 - 3.38 |
3.38 - 3.4 |
|
Close:
|
3.5 - 3.53 |
3.53 - 3.56 |
|
Company Description |
|
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. |
Headline News |
Thu, 18 May 2023
NanoVibronix Issues Letter to Shareholders - Business Wire
Tue, 18 Apr 2023
NanoVibronix Issues Letter to Shareholders - Yahoo Finance
Tue, 28 Mar 2023
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS) - Yahoo Finance
Wed, 22 Feb 2023
NanoVibronix to Launch Rental Program for PainShield and UroShield - Business Wire
Wed, 08 Feb 2023
NanoVibronix Announces Reverse Stock Split - Business Wire
Wed, 18 Jan 2023
NanoVibronix Provides Update on Expanding Access to PainShield - Business Wire
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
2 (M) |
| Shares Float |
2 (M) |
|
% Held by Insiders
|
0.6 (%) |
|
% Held by Institutions
|
7.1 (%) |
|
Shares Short
|
33 (K) |
|
Shares Short P.Month
|
16 (K) |
Stock Financials |
|
EPS
|
-3.25 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.33 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-563.4 |
|
Return on Assets (ttm)
|
-47.1 |
|
Return on Equity (ttm)
|
-145.1 |
|
Qtrly Rev. Growth
|
30.1 |
|
Gross Profit (p.s.)
|
0.1 |
|
Sales Per Share
|
0.5 |
|
EBITDA (p.s.)
|
-2.84 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-6 (M) |
|
Levered Free Cash Flow
|
-4 (M) |
Stock Valuations |
|
PE Ratio
|
-1.08 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
2.62 |
|
Price to Sales
|
6.94 |
|
Price to Cash Flow
|
-0.9 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
